MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
|
Back to Search Results |
|
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Information (3190)
|
Event Date 09/03/2014 |
Event Type
Injury
|
Event Description
|
It was reported that a retrospective administrative database study was performed of over 90,000 patients who underwent cervical spine procedures in the united states from 2006 to 2010.The authors used the marketscan research database.91,543 of the patients in the marketscan database underwent acdf (with or without concomitant cervical corpectomy, and with or without concomitant posterior cervical spine procedures); 3179 of these patients received rhbmp intraoperatively.148 patients in the rhbmp cohort required readmission within 30 days of the index procedure.
|
|
Manufacturer Narrative
|
Article citation: cole et al.Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the marketscan longitudinal database.J bone joint surg am.2014;96:1409-16.Pt age: average age: 50.8 yrs.Pt gender: 1415 males, 1764 females.Date of implant: between 2006 ¿ 2010.(b)(6).(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.
|
|
Search Alerts/Recalls
|
|
|